Royal Bank of Canada
AEGR

Royal Bank of Canada’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-36,200
Closed -$108K 6078
2016
Q3
$108K Sell
36,200
-18,010
-33% -$53.7K ﹤0.01% 4056
2016
Q2
$81K Sell
54,210
-4,037
-7% -$6.03K ﹤0.01% 4198
2016
Q1
$216K Buy
58,247
+53,722
+1,187% +$199K ﹤0.01% 3680
2015
Q4
$45K Buy
+4,525
New +$45K ﹤0.01% 4635
2015
Q3
Sell
-9,739
Closed -$185K 6242
2015
Q2
$185K Buy
+9,739
New +$185K ﹤0.01% 3956
2015
Q1
Sell
-162,936
Closed -$3.41M 5918
2014
Q4
$3.41M Buy
162,936
+79
+0% +$1.65K ﹤0.01% 1571
2014
Q3
$5.44M Buy
162,857
+5,539
+4% +$185K ﹤0.01% 1319
2014
Q2
$5.05M Buy
157,318
+156,918
+39,230% +$5.04M ﹤0.01% 1389
2014
Q1
$19K Buy
400
+384
+2,400% +$18.2K ﹤0.01% 4694
2013
Q4
$1K Sell
16
-5,422
-100% -$339K ﹤0.01% 5210
2013
Q3
$466K Buy
5,438
+5,149
+1,782% +$441K ﹤0.01% 2931
2013
Q2
$18K Buy
+289
New +$18K ﹤0.01% 4483